Francesca Colavita
Overview
Explore the profile of Francesca Colavita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
2034
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Focosi D, Colavita F, Meschi S, Lalle E, Franchini M, Maggi F
Rev Med Virol
. 2025 Mar;
35(2):e70031.
PMID: 40064585
In 2024, a novel recombinant of the Oropouche virus emerged as a potential threat. This virus has caused a significant outbreak in Brazil and Cuba, with imported cases subsequently reported...
2.
Minosse C, Spezia P, Mazzotta V, Matusali G, Meschi S, Colavita F, et al.
Vaccines (Basel)
. 2025 Feb;
13(2).
PMID: 40006700
: Torquetenovirus (TTV) viremia is increasingly recognized as a marker of immune competence. In the context of COVID-19, TTV viral load (VL) has been shown to predict anti-Spike antibody levels...
3.
Mazzotta V, Piselli P, Lepri A, Matusali G, Cimini E, Esvan R, et al.
Vaccines (Basel)
. 2025 Jan;
13(1).
PMID: 39852811
Background: The recent resurgence of mpox in central Africa has been declared a new public health emergency of international concern (PHEIC) requiring coordinated international responses. Vaccination is a priority to...
4.
Casetti R, Sacchi A, Mazzotta V, Cristofanelli F, Grassi G, Gili S, et al.
Int Immunopharmacol
. 2025 Jan;
148:113934.
PMID: 39832460
The impact of anti-Spike monoclonal antibody (mAbs) treatment on the immune response of COVID19-patients is poorly explored. In particular, a comparison of the immunological influence of different therapeutic regimens has...
5.
Colavita F, Carletti F, DAbramo A, Nicastri E, Maggi F
Lancet Infect Dis
. 2024 Dec;
25(1):e11-e12.
PMID: 39653052
No abstract available.
6.
Matusali G, Cimini E, Mazzotta V, Colavita F, Maggi F, Antinori A
J Infect
. 2024 Oct;
89(6):106309.
PMID: 39368640
No abstract available.
7.
Meschi S, Colavita F, Matusali G, Focosi D, Maggi F, Franchini M
Transfusion
. 2024 Aug;
64(8):1588-1589.
PMID: 39126316
No abstract available.
8.
De Masi S, Da Cas R, Ippolito F, Baglio G, Zoccali C, Chiarotti F, et al.
J Nephrol
. 2024 Jul;
37(7):1871-1880.
PMID: 38995613
Background: The aim of this study was to evaluate the impact on the national health system of COVID-19 infection in vaccinated patients undergoing haemodialysis. Methods: From the cohort of vaccinated...
9.
Meschi S, Colavita F, Carletti F, Mazzotta V, Matusali G, Specchiarello E, et al.
Sci Rep
. 2024 Jun;
14(1):13487.
PMID: 38866796
Since spring 2022, the global epidemiology of the monkeypox virus (MPXV) has changed. The unprecedented increase of human clade II MPXV cases worldwide heightened concerns about this emerging zoonotic disease....
10.
Matusali G, Mazzotta V, Meschi S, Colavita F, Gagliardini R, Bettini A, et al.
J Med Virol
. 2024 Apr;
96(5):e29631.
PMID: 38682689
No abstract available.